Ascendis Pharma A/S, a global pharma company applying its innovative TransCon technology platform to build a leading and fully integrated biopharma company focused on making a meaningful difference in ...
A large study found that greater exposure to long-term air pollution was linked with increased risks for blood clots that can occur in deep veins, which, if untreated, can block blood flow and cause ...
Vir Biotechnology, Inc, a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and ...
BeiGene, Ltd., a global oncology company that intends to change its name to BeOne Medicines Ltd., announced it has entered into a global licensing agreement with CSPC Zhongqi Pharmaceutical Technology ...
AIIMS signs MoU with Wipro GE Healthcare to establish ‘AI Health Innovations Hub’ to advance precision health solutions for India & the world: Our Bureau, Mumbai Saturday, Dec ...
Roche’s new and updated molecular cobas 6800/8800 systems receives CE certification: Basel Saturday, December 14, 2024, 15:00 Hrs [IST] Roche announced the CE certification of t ...
The Uttar Pradesh government will provide one 100-bed, two 20-bed, small 8-bed hospital at Prayagraj Mahakumbh-2025 as a part ...
The Indian pharmaceutical industry is set to make a powerful statement on the global stage at the Clinical Pharmacy Congress London (CPCL) 2025, Europe’s largest and most prestigious gathering of ...
Pharmacy career is viewed as recession-resistant due to several key factors that contribute to its resilience during economic downturns. The ongoing advancement in pharmaceutical sciences and the ...
The Department of Pharmaceuticals (DoP) has re-opened the application window for the sub-scheme to assist pharma units to set up common facilities, under the scheme for Strengthening of ...
Bayer initiates phase I study with SOS1 inhibitor, BAY3498264 in patients with advanced KRAS-mutated tumours: Berlin Saturday, December 14, 2024, 13:00 Hrs [IST] Bayer announced i ...
EMA approves Roche’s Vabysmo prefilled syringe for three retinal conditions that can cause blindness: Basel Saturday, December 14, 2024, 10:00 Hrs [IST] Roche announced that the ...